Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
317.50    0.50 (0.16%)
Bid:
315.50
Ask:
317.00
Spread: 1.50 (0.475%)
Market Cap: £732.37m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Director/PDMR Shareholding

16 Jun 2020 11:31

RNS Number : 1180Q
Chesnara PLC
16 June 2020
 

CHESNARA plc

("Chesnara" or "the Company")

 

LEI Number: 213800VFRMBRTSZ3SJ06

16 June 2020

NOTIFICATION OF PDMR DEALING

 

 

Chesnara plc (the 'Company') today announces that PDMR Mark Hesketh has purchased ordinary shares through his Dividend Reinvestment Plan election.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Hesketh

2

Reason for the notification

a)

Position/status

Non Executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Chesnara plc

b)

LEI

213800VFRMBRTSZ3SJ06

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Chesnara plc Ordinary shares of 5 pence each (Shares)

ID Code: (GB00B00FPT80)

b)

Nature of the transaction 

Market (DRIP) Purchase

c)

Price(s) and volume(s)

Price(s): 303.75p. Volume: 229.

d)

Aggregated information

N/A

e)

Date of the transaction

11 June 2020

f)

Place of the transaction

London Stock Exchange (XLON)

 

The above notification is made in accordance with the requirements of the EU Market Abuse Regulation.

 

For further information, please contact:

 

Roddy Watt

Director, Capital Markets

FWD

Forward thinking communications

 

T - 020 7280 0651

E - roddy.watt@fwdconsulting.co.uk 

 

Notes to Editors

Chesnara is a life and pensions company listed on the London Stock Exchange. It administers over one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.

 

Following a three pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.

 

Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 15 years in succession.

 

Further details are available on the Company's website (www.chesnara.co.uk).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHGPUUWQUPUGUQ
Date   Source Headline
24th Oct 20227:00 amRNSBlock listing Interim Review
19th Oct 20227:00 amRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSAppointment of Group GC & Company Secretary
29th Sep 20227:00 amRNSBlock Listing Application
12th Sep 20227:15 amEQSHardman & Co Research on Chesnara Plc (CSN): Robust cash generation in challenging markets
8th Sep 202212:05 pmEQSHardman Talks Video: Interview Chesnara management discuss 2022 half-year results
2nd Sep 20227:00 amRNSHolding(s) in Company
31st Aug 20227:00 amRNSHalf-year Report
23rd Aug 20227:00 amRNSHolding(s) in Company
17th Aug 20227:00 amRNSNotice of Interim Results
15th Aug 20222:45 pmEQSHardman & Co: Q&A on Chesnara Plc (CSN) Conservatrix acquisition boosts AuA and cash flow with capacity for more
8th Aug 20227:00 amRNSHolding(s) in Company
5th Aug 20227:00 amRNSHolding(s) in Company
2nd Aug 20227:00 amRNSChesnara Enhances M&A and Commercial Capabilities
29th Jul 20227:15 amEQSHardman & Co Research: Chesnara plc (CSN): Another fine acquisition
22nd Jul 20227:00 amRNSAcquisition
16th Jun 20229:15 amEQSHardman & Co Research: Q&A on Chesnara Plc (CSN): Good performance analysed
31st May 20227:00 amRNSTotal Voting Rights
24th May 20227:00 amEQSHardman & Co Research : Chesnara plc (CSN): Market benefits overwhelm operational challenges
17th May 20221:51 pmRNSResult of AGM
29th Apr 20227:00 amRNSDirector/PDMR Shareholding
28th Apr 20227:00 amRNSAcquisition Completions
22nd Apr 20227:00 amRNSBlock listing Interim Review
21st Apr 20227:00 amRNSNotice of AGM
8th Apr 20227:00 amRNSAcquisition Update
5th Apr 20222:30 pmRNSDirector/PDMR Shareholding
31st Mar 20227:00 amRNSFinal Results
17th Mar 20227:00 amRNSNotice of Results
15th Mar 20227:00 amRNSTotal Voting Rights
14th Feb 20227:00 amRNSDirectorate Change
2nd Feb 20223:07 pmRNS£200m Inaugural Tier 2 Subordinated Notes Issuance
26th Jan 20227:00 amRNSHolding(s) in Company
17th Jan 20227:00 amRNSDirectorate Change
17th Dec 20217:00 amRNSSenior Leadership Appointment
9th Dec 20217:00 amRNSHolding(s) in Company
2nd Dec 20211:50 pmEQSHardman & Co Research : Chesnara (CSN) Initiation of Coverage: Could be the least worrying dividend you'll get
26th Nov 20211:00 pmRNSDirector/PDMR Shareholding
25th Nov 20217:00 amRNSAcquisition
22nd Oct 20217:00 amRNSBlock listing Interim Review
19th Oct 20217:00 amRNSDirectorate Change
13th Sep 20217:00 amRNSProposed Acquisition
7th Sep 20217:00 amRNSHolding(s) in Company
26th Aug 20217:00 amRNSHalf-year Report
12th Aug 20217:00 amRNSNotice of Results
2nd Aug 20217:00 amRNSDirectorate Change
28th May 20214:36 pmRNSHolding(s) in Company
28th May 20217:00 amRNSTotal Voting Rights
21st May 20217:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
18th May 20213:30 pmRNSResult of AGM
12th May 20217:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.